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Hypothermic machine perfusion (HMP) has become standard care in many center’s to 
preserve kidneys donated after circulatory death (DCD). Despite a significant reduction in 
metabolism at low temperatures, remaining cellular activity requires oxygen. Since the role 
and safety of oxygen during HMP has not been fully clarified, its supply during HMP is not 
standard yet. This study investigates the effect of administering oxygen during HMP on renal 
function in a porcine DCD model.  
Methods: 
After 30 minutes of warm ischemia, porcine slaughterhouse kidneys were preserved for 24 
hours by means of cold storage (CS), or HMP with Belzer Machine Perfusion Solution (UW- 
MPS) supplemented with no oxygen, 21% or 100% oxygen. Next, kidneys were reperfused 
for 4 hours in a normothermic machine perfusion (NMP) setup.  
Results: 
HMP resulted in significantly better kidney function during NMP. Thiobarbituric acid-
reactive substances (TBARS), markers of oxidative stress, were significantly lower in HMP 
preserved kidneys. HMP preserved kidneys showed significantly lower ASAT and LDH 
levels compared to kidneys preserved by CS. No differences were found between the HMP 
groups subjected to different oxygen concentrations. ATP levels significantly improved 
during HMP when active oxygenation was applied. 
Conclusion: 
This study showed that preservation of DCD kidneys with HMP is superior to CS. Although 
the addition of oxygen to HMP did not result in significantly improved renal function, 
beneficial effects were found in terms of reduced oxidative stress and energy status. Oxygen 








Persistent organ shortage in transplantation results in the use of sub-optimal quality organs. In 
addition, the number of donations after brain death (DBD) from donors younger than 50 
without comorbidities or so-called standard criteria donors (SCD) is  decreasing.
1
 As a result, 
allografts from donors deceased due to a circulatory arrest are increasing in a number of 
countries.
1
 Kidneys retrieved from such donors are more prone to ischemia-reperfusion 
injuries and are associated  with a significantly higher incidence of delayed graft function 
(DGF).
2 
DGF results in the necessity of dialysis after transplantation until the kidney recovers 
its function.
3
 DGF, therefore, affects the quality of life of the recipient and it also appears to 
be a risk factor for acute cellular rejection and poorer long-term outcomes.
4 
Hypothermic 
machine perfusion (HMP) as preservation modality has already been proven to reduce the 
incidence and duration of DGF compared to cold storage(CS).
2,3,5,6  
Both CS and HMP are based on the suppression of metabolism due to hypothermia. Notably, 
even at 4 degrees Celsius, approximately 10% of physiological metabolic rate remains. This 
suggests that oxygen continues to be consumed and its addition during preservation might be 
beneficial to support ongoing metabolism. HMP offers the possibility to provide the kidney 
with oxygen during the preservation period. However, oxygen supply during preservation is 
not standard of care and kidneys are usually perfused without oxygen.  
Next to limited experimental and preclinical evidence, clinical proof of the need of oxygen 
during HMP is also still lacking.
5,7–9
 Therefore, two international, double blinded, 
randomized controlled trials are currently ongoing to assess the efficacy of 100% oxygen 
addition during HMP of older donation after circulatory death (DCD) kidneys and in 
expanded criteria donor (ECD) kidneys.
10,11  
Furthermore, safety of the addition of oxygen at 
whatever level during preservation, remains a matter of concern. In addition, the work that 







oxygen or on HMP with different oxygen concentrations only. A study comparing CS with 
HMP with different oxygen concentrations using a clinically approved preservation solutions 
is still lacking. We, therefore, combined all strategies. Our aim was to provide a 
comprehensive evaluation about the effects of different oxygen concentrations during HMP 
of porcine kidneys compared to CS preservation. Besides early renal function, we want to 
address the safety of different oxygen concentrations by means of the release of reactive 
oxygen species (ROS), and the effect of oxygen during HMP on the metabolism of the 
kidney. In order to avoid the use of laboratory animals we used a porcine DCD kidney 
slaughterhouse model as previously developed in our lab.  
Materials and methods 
Animal model 
Porcine kidneys were obtained from two abattoirs. Pigs were slaughtered by a standardized 
procedure of sedative electric shock followed by exsanguination. Immediately, 1 liter of 
blood was collected in a container containing 25.000 IU of heparin (LEO Pharma A/S, 
Ballerup, Denmark). Since we made use of slaughterhouse waste material as our organ and 
blood source, no animal ethics committee approval was needed. 
Experimental design 
Warm ischemic time (WIT) of thirty minutes was chosen to induce ischemic injury. The four 
different preservation techniques used were applied for 24 hours: cold storage (CS), non 
oxygenated hypothermic machine perfusion (HMP0%), hypothermic machine perfusion with 
21% oxygen (HMP21%) or 100% oxygen addition (HMP100%). All kidneys were subsequently 
reperfused in an ex vivo normothermic machine perfusion (NMP) setup for a total duration of 








Cold storage and hypothermic machine perfusion 
After warm ischemia the kidney was flushed with 180 ml saline at 4° Celsius (Baxter BV, 
Utrecht, The Netherlands). A cortical biopsy was taken (Invivo, Best, The Netherlands) and 
stored in sonification solution (SONOP containing 0.372 g EDTA in 130 mL H2O and NaOH 
(ph 10.9) + 370 mL 96% ethanol) and 4% buffered formaldehyde for further analysis. In the 
CS group the kidneys were stored in a bag, submerged in 500 mL University of Wisconsin 
solution (Belzers CS, Bridge to life Ltd., London, United Kingdom) and stored on melting 
ice. In the HMP groups the kidneys were cannulated to connect the renal artery to the HMP 
device (Kidney Assist Transport, Organ Assist, Groningen, The Netherlands). A total of 500 
mL University of Wisconsin machine perfusion solution (Belzers MP, Bridge to life Ltd., 
London, United Kingdom) was used as perfusion solution. Preservation was performed at 
4°C with a pulsatile pressure-controlled perfusion with a mean arterial pressure of 25 mmHg. 
Either, no oxygen, 21% or 100% oxygen was supplied to the oxygenator (Hilite LT 1000, 
Medos Medizin technik AG, Stolberg, Germany) with a fixed flow rate of 100 ml/min. 
Perfusion solution samples were taken after 15, 60 minutes and 24 hours. Perfusion 
parameters, such as pressure, temperature and flow rates were monitored continuously.  
Ex vivo normothermic machine perfusion to assess renal function 
After 24 hours of preservation, renal function was assessed in an isolated ex vivo 
normothermic machine perfusion setup. The renal artery and ureter were cannulated with a 12 
and 8 French cannula, respectively. The kidneys were flushed with 50 ml of saline (4°) to 
remove remaining preservation solution. Afterwards the kidneys were weighed and another 
biopsy was taken and stored as described above. 
The kidney was placed in an organ chamber and perfused at 37°C for 4 hours with a pressure-
controlled pulsatile pump at a mean pressure of 75 mmHg (Kidney Assist Transport, Organ 







O2 and 5% CO2 through the oxygenator (Hilite LT 1000, Medos Medizin technik AG, 
Stolberg, Germany) with a fixed flow rate of 500 ml/min. The setup was surrounded by a 
heating cabinet with a feedback system, keeping the ambient temperature at 37°C. The 
perfusion medium consisted of 500 ml heparinized, leukocyte-depleted autologous whole 
blood. Leukocyte-depletion was carried out with a leukocyte filter (Bio R O2 plus, Fresenius 
Kabi, Zeist, The Netherlands). The blood was diluted with 300 ml of lactated Ringer’s 
(Baxter BV, Utrecht, The Netherlands), containing 6 mg Mannitol (Sigma-Aldrich, St Louis, 
USA), 6 mg Dexamethasone (Centrafarm, Etten-Leur, The Netherlands) 10 ml 8,4% sodium 
bicarbonate (B Braun Melsungen AG, Melsungen, Germany), 90 mg creatinine (Sigma-
Aldrich, St Louis, USA), 1000mg/200mg Amoxicilline /Clavulanic acid (Sandoz BV, 
Almere, The Netherlands), and 100 µl 20 mg/ml sodium nitroprusside (Sigma-Aldrich, St 
Louis, USA). Furthermore, a continuous supply of nutrients consisting of 10% Aminoplasmal 
(Braun Melsungen AG, Melsungen, Germany), 2.5 ml 8,4% sodium bicarbonate, and 17 IU 
Novorapid, (Novo Nordisk, Bagsvaerd, Denmark) was added to the perfusion circuit at a rate 
of 20 ml/h. 5% glucose (Baxter BV, Utrecht, The Netherlands) was administered when 
glucose levels dropped below 5 mmol/L. 
Evaluation of renal function 
During the testing period, renal flow rate and urine production were measured every 15 
minutes. Blood and urine samples were taken after 15, 60, 120, 180 and 240 minutes. At 
these same time points arterial and venous blood samples were taken for blood gas analysis 
(ABL90 FLEX, Radiometer, Zoetermeer, The Netherlands). 
Concentrations of creatinine and sodium were determined in blood and urine, using routine 
procedures at the clinical chemistry lab of the University Medical Center Groningen 
(UMCG). Creatinine clearance served as the primary functional endpoint of this study.                                                                                                                            







assessed using fractional sodium excretion and urine protein content, respectively. Proteins in 
the urine were measured in a standardized manner at the clinical chemistry lab of the UMCG.  
Metabolic activity 
Calculating the renal oxygen consumption (QO2) approximated metabolic activity of the 
kidneys. The difference between the venous and arterial dissolved and bound oxygen was 







((((𝐻𝑏 ∗ 2,4794) + (𝑝𝑂2𝑎𝑟𝑡𝑒𝑟𝑖𝑎𝑙 ∗ 𝐾)) − ((0,024794 ∗ 𝐻𝑏 ∗ 𝑆𝑂2 𝑣𝑒𝑛𝑜𝑢𝑠 ) + (𝑝𝑂2 𝑣𝑒𝑛𝑜𝑢𝑠 ∗
𝐾))) ∗  𝑄) /𝑔) ∗ 100           
Where Hb is the perfusates hemoglobin content in mmol/L, pO2 is the partial oxygen pressure 
arterial or venous in kPa, K is the solubility constant of oxygen in water at 37°C and equals 
0.0225 (mL O2 per kPa), SO2 is the saturation in %, Q is the renal blood flow in L/min and g 
is the kidney weight in grams.  
Adenosine triphosphate (ATP) was analyzed in biopsies that were taken before and after the 
preservation period, and at the end of reperfusion. ATP content was determined according to 
a standard protocol and expressed in µmol/g protein.
12
 
Metabolic coupling of sodium transport by ATPase in tubular epithelial cells was calculated 








((𝐶𝑟𝑐𝑙𝑒𝑎𝑟𝑎𝑛𝑐𝑒 ∗  𝑃𝑙𝑎𝑠𝑚𝑎𝑆𝑜𝑑𝑖𝑢𝑚 ) − (𝑈𝑟𝑖𝑛𝑒 𝑓𝑙𝑜𝑤 ∗ 𝑈𝑟𝑖𝑛𝑒𝑆𝑜𝑑𝑖𝑢𝑚 ))
𝑄𝑂2
 
Oxidative stress due to active oxygenation 
Thiobarbituric acid-reactive substances (TBARS) were measured as indicator of oxidative 







protocol for this analysis has been described in detail previously.
12
 TBARS concentrations 
are expressed in µM. 
Kidney injury markers           
Enzymatic activities of lactate dehydrogenase (LDH), and aspartate aminotransferase 
(ASAT) were determined at the clinical chemistry lab of the UMCG according to standard 
procedures. Urinary N-acetyl-beta-D-glucosaminidase(uNAG) was determined following a 
protocol described previously by our lab.
12,13 
Histological examination and morphology scoring 
Kidney biopsies were fixed by immersion in 4% buffered formaldehyde, embedded in 
paraffin and cut into 4 µm slices. These sections were stained with haematoxylin-eosin 
(H&E). Ischemia reperfusion injury was scored on the basis of 3 criteria
14
: proximal tubular 
cell edema, tubular cell vacuolation and proximal tubular cell necrosis. Every item was given 
a score between 1 and 5, as representing no signs of edema, vacuoles or cell necrosis (score 
1), minor (score 2), medium (score 3), severe (score 4) or extreme signs (score 5). The 
biopsies were randomly assigned  to two independent experienced examiners for light 
microscopy evaluation.  
Statistics 
Results are reported as means with standard deviations. Statistical analysis was performed 
with IBM SPSS Statistics 23. Area under the curve (AUC) was calculated for renal flow rates 
during HMP and NMP, creatinine clearance and oxygen consumption rates. All other markers 
were tested for significant differences at every time point. Groups were compared using a 
Kruskal-Wallis test followed by a Mann-Whitney U posthoc test. P<0.05 was considered to 








Hypothermic and normothermic perfusion parameters 
All HMP groups showed similar flow patterns in the cold, starting with a steep increase 
within the first twenty minutes and a slow increase thereafter until the end of preservation 
(Figure 1A). No statistical differences in flow rate during HMP was found.  
During the period of NMP, renal blood flow increased during the first 120 minutes in every 
group, and slowly decreased thereafter (Figure 1B). The CS group showed a trend towards a 
higher mean flow rate (p=0.072)) compared to the HMP groups.  
Renal function during normothermic perfusion 
In terms of creatinine clearance all HMP groups showed significantly higher clearances at 
every time point in comparison to the CS group. The HMP100% group presented the highest 
clearance rate. It was, however, not significantly different from the HMP0% and HMP21% 
groups (Figure 2A). Proteinuria in CS kidneys was significantly higher than in HMP groups 
(Figure 2B). HMP kidneys had reduced urinary levels of protein, but no differences were 
observed within the 3 HMP groups. Significant improvement in fractional sodium excretion 
levels was found when HMP was applied. Again no differences were found when comparing 
the different oxygen concentrations (Figure 2C). In all groups urine production was the 
highest during the first fifteen minutes after reperfusion (Figure 2D).  
Metabolic activity during normothermic perfusion  
Oxygen consumption rates were significantly higher in all HMP groups compared to the CS 
kidneys. Although renal function in the CS kidneys was almost absent (filtration < 0.1 
mL/(min.100g; FENa% > 70%), oxygen consumption was still present (Figure 3A). 
After 30 minutes WIT and before preservation was initiated, ATP was almost completely 
depleted in every group (Figure 3B, timepoint 0.5). CS for 24 hours resulted in complete loss 







or 100% yielded significant higher ATP during 24 hours preservation in these groups (Figure 
3B, timepoint 24). 4 hours of NMP resulted in significant lower ATP levels in the HMP0% 
group, while the other groups showed similar ATP levels (Figure 3B, timepoint 28).  
Metabolic coupling ratio was improved in HMP perfused kidneys and was significantly 
improved after 120 and 180 minutes after start reperfusion in all HMP kidneys compared to 
CS kidneys (Figure 3C).  
Oxidative stress due to active oxygenation 
TBARS measured in the preservation solution during HMP were negligible in all groups at 
every time point (Figure 4A). TBARS in the perfusate were significantly higher after 120 
minutes in the CS kidneys compared to the HMP groups, and slowly decreased in the HMP 
groups over the 4 hours NMP period (Figure 4B). The urinary TBARS showed an immediate 
increase during the first hour of reperfusion in all HMP groups, but decreased thereafter. The 
CS group had a gradual increasing concentration of TBARS in the urine and has a higher 
value (not significant) at the end of 4 hours perfusion (Figure 4C).  
Kidney injury markers 
LDH values remained stable in the HMP groups while the CS kidneys showed a rise in LDH 
levels in the (NMP) perfusate over time (Figure S1A, SDC, http://links.lww.com/TP/B723). 
At the end of 4 hours reperfusion, LDH levels were significantly higher in the CS group.                                                                                              
Urinary N-acetyl-beta-D-glucosaminidase (uNAG) remained stable during 4 hours in the 
HMP groups. The CS kidneys showed a significant increased value from the onset of 
reperfusion and also a rise over time (Figure S1B, SDC, http://links.lww.com/TP/B723). All 
3 HMP groups have a similar trend for ASAT levels; however, there is a significant benefit 
for the 100% oxygen group in comparison with the HMP0% and CS groups. Similar for LDH 
and NAG, the CS group showed an increase over a time and significant higher levels of 








During histological examination it became clear that the stage of damage was already beyond 
the point of vacuolation and that proximal tubular cell necrosis was already detectable. The 
histological scoring resulted in the following mean necrosis scores: 2.17±0.49, 2.60±0.55, 
2.67±0.82 for the HMP 0, 21 and 100% groups, respectively. This was significantly lower 
than the average necrosis for the CS kidneys (of 4.7±0.49; Figure S2A, SDC, 
http://links.lww.com/TP/B723). 
The average edema score for CS, HMP 0, 21 and 100 were comparable, with scores of 2.0±0, 
2.50±0.84, 2.20±0.84, and 2.5±0.58, respectively (Figure S2B, SDC, 
http://links.lww.com/TP/B723).  
Discussion 
In this study we evaluated the effect of different oxygen concentrations during HMP on renal 
function with a clinically approved perfusion solution. We found that HMP is superior to CS 
in terms of creatinine clearance and fractional sodium excretion. Active oxygenation during 
preservation did not result in significant advantages with regard to renal function in this 
porcine DCD model. Only for ASAT and ATP levels, a significant beneficial effect of 
oxygen was found. No signs of oxidative stress through the addition of oxygen during 
preservation were observed.  
Experimental research on the addition of oxygen during HMP is scarce. There are only two 
studies that assessed CS versus 100% oxygenated HMP in preclinical porcine (auto) 
transplantation models. Both were able to show the significant beneficial effects of 
oxygenated HMP in comparison to CS on renal function.
5,7 
This result corresponds with our 
findings. However, non oxygenated HMP was not included and the addition of oxygen can 
therefore not be assessed. Furthermore, in another study, short-term effects of oxygen during 
HMP was addressed in a reperfusion model.
8 







during the preservation of DCD kidneys in terms of function and injury. Unfortunately, we 
were not able to reproduce these findings, however, there are some major differences in setup 
of these studies. One of these differences is that we used porcine slaughterhouse kidneys. The 
downside of using these is that not only the conditions of the experiment are less controlled 
but also baseline quality of these kidneys is not controllable since we are not allowed to take 
samples at life. Therefore, we cannot elaborate on preexisting injury and the amount of injury 
induced by warm ischemia that we have chosen in this study. Animal welfare inspired us to 
develop a slaughterhouse model since ethical considerations concerning the use of animals 
for scientific research is an important topic in the Netherlands. We believe that 
slaughterhouse organs can provide us reliable and translational data and we are not the first 
group believing in slaughterhouse organs for machine perfusion research.
15–18
 Nath et al 
already demonstrated similarity in metabolic processes between human and slaughterhouse 
pig kidneys, which provides additional confidence in these kidneys for scientific research.
16
 
One prerequisite to make sure that the slaughtering procedure does not negatively influence 
the outcome we streamlined the process with our local butchers by explaining them our goals 
and procedures such as ischemic times and appropriate handling of blood and organs.   
The reason for conducting this study was to assess a clinically approved HMP device in 
combination with a clinically approved perfusion solution. Hoyer et al used an experimental 
perfusion solution, Histidine-tryptophan-ketoglutarate –N, and their results can therefore not 
be directly extrapolated to the current clinical situation.
8
 In our setup, UW-MP solution was 
used, which is currently the only approved clinical machine perfusion solution for 
preservation of kidney grafts. The oxygen carrying capacity of UW-MP solution was not 
measured in this study but has been measured before. The amount of dissolved oxygen 
present in UW-MP is approximately 70 kPa, and 21 kPa with the addition of 100 ml/min 
100% and 21% oxygen, respectively.
17,19,20







delivered to kidneys cells and supports aerobic metabolism, as reflected by both adenosine 
monophosphate (AMP), adenosine diphosphate (ADP) and ATP levels in both the medulla 
and cortex of the kidneys when UW-MPS solution is used.
17
  
The only other comparable study on different oxygen concentrations during HMP was 
performed in a porcine DCD auto transplantation model.
9
 This group was able to show that 
animals transplanted with HMP0% oxygen had significantly higher peak creatinine levels at 
day 5 post transplant in comparison to pigs that were transplanted with HMP100% oxygen 
kidneys. The effect of oxygen was still present at the 3-month follow up, shown by 
significantly lower serum creatinine levels and a significantly reduced proteinuria. These 
significant differences first became apparent at day 5 after transplantation. Long-term 
function cannot be assessed with reperfusion duration of only 4 hours and a (auto) 
transplantation model is necessary to address chronic injury and long-lasting quality and 
function. Another possibility would be longer reperfusion times. However, NMP as 
reperfusion modality also has its limits. NMP up to 24 hours are reported but maintaining a 
physiological electrolyte content and pH is problematic.
21–23
 In our study, we only tested 
kidney function for four hours. This interval could be too short to find conclusive results 
concerning active oxygenation in our model. In the end, the ongoing clinical studies need to 
answer the question of oxygen during HMP is beneficiary for the long-term quality of 
transplanted kidneys.  
Both studies addressed in the prior paragraph, conclude that active oxygenation during HMP 
of DCD kidneys is beneficial in terms of renal function. We were not able to show this. 
However, we do see a trend in favor of active oxygenation during long-term HMP. Kidney 
quality is, however, more than function alone. Therefore, we performed supplementary 
analyses to address a broad range of other quality and injury markers. With these we can 







Oxygen consumption during NMP was calculated as indicator of metabolic activity and a 
significantly lower consumption was found for CS kidneys. Similar oxygen consumption 
rates were found for the different HMP groups and were in-line with renal function. We think 
that oxygen consumption could function as a suitable quality marker during NMP. This is 
supported by studies comparing subnormothermic machine perfusion with HMP and CS, 
where significant improvements in oxygen consumption were found for kidneys that were 
better preserved in terms of function.
24,25
 Two different formulae are described; the first 
considering only dissolved oxygen,
26
 the second also considering hemoglobin-bound 
oxygen.
24
 In our model, variations in hemoglobin (Hb) and venous saturations were present, 
which urges us to make use of the more complicated formula.   
In addition to oxygen consumption, metabolic coupling was calculated. This provides 
information regarding efficient use of oxygen for ATP production and subsequent active 
transport of sodium ions over the tubules. We observed a significant improvement in 
metabolic coupling at time points t=120 and 180 for all HMP groups. This result is in-line 
with the fractional sodium excretion. All HMP kidneys are able to transport sodium in 
comparison to the CS kidneys. This active sodium transport requires ATP as energy source. 
We found a significantly lower ATP content after reperfusion in the HMP0% group and it is 
likely that the total ATP production and usage during NMP is balanced to make active 
sodium transport possible causing this lower ATP content after reperfusion in the non 
oxygenated HMP group. The required net ATP content in the oxygenated groups after 
reperfusion indicates that the addition of oxygen during HMP leads to better mitochondrial 
function. ATP levels in the CS group, however, indicate a low usage of ATP since metabolic 
coupling is poor in this group. It is also likely that mitochondrial function is disturbed in the 
CS group. TBARS levels in the plasma support that there is indeed a distortion in the 







kidneys. Furthermore, mitochondrial damage can also be assessed with ASAT, which is 
present in the cytoplasm of mitochondria. In this isolated perfusion system the only source 
are kidney mitochondria and, therefore, serves as a valuable marker for mitochondrial 
damage. In-line with the TBARS levels, there are the significantly higher ASAT levels, 
indicating more mitochondrial damage in the CS compared to the HMP kidneys. In favor of 
100% oxygenation during HMP are the significant lower ASAT levels in comparison with 
HMP0% and HMP21High oxygen concentrations during HMP resulted in better restoration of 
tissue ATP content in this study. This given is also supported by Patel et al, showing not only 
increased levels of AMP, ADP and ATP, but also increased lactate and alanine levels, 
metabolites of glycolysis, indicating a switch to anaerobic metabolism when insufficient 
oxygen was supplied to the cells.
17
 A short period of oxygenated HMP after CS has been 
shown to reestablish cellular respiration, resulting in improved preservation of rat kidneys
27
 
and rat and porcine livers.
28,29
 Long-term oxygenated HMP seem to result in improved 
cellular respiration as well, considering the ATP levels that we and others found.
17
 It clearly 
proves that at low temperatures metabolism is ongoing and should be supported by 
oxygenation.  
In conclusion, cellular energy status significantly improved when active oxygenation was 
applied during long-term HMP in this slaughterhouse reperfusion model. Although a trend 
towards preservation benefits was seen during NMP, this never reached a statistical 
significance. Long-term HMP on itself, significantly improved renal function, tissue integrity 
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Figure 1. Flow rates during preservation and testing.   
Porcine kidneys were treated with hypothermic machine perfusion with the addition of 0, 21 
or 100% oxygen or cold storage. (A) Renal flow rates during 24 hours kidney preservation, 
(B) Renal flow rates during functionality testing. CS, cold storage; HMP 0%, hypothermic 
machine perfusion with no oxygen; HMP 21%, hypothermic machine perfusion oxygenated 
with air; HMP 100%, hypothermic machine perfusion with 100% oxygen. The data are 
shown as mean±SD. 
Figure 2. Parameters of renal function at 15, 60, 120, 180 and 240 minutes after 
normothermic machine perfusion.  
Porcine kidneys underwent 4 hours of normothermic autologous blood perfusion after 24 
hours preservation to test renal function (A) Creatinine clearance,  (B) Total protein content 
in urine, (C) Fractional sodium excretion, and (D) Urine production. CS, cold storage; HMP 
0%, hypothermic machine perfusion with no oxygen; HMP 21%, hypothermic machine 
perfusion oxygenated with air; HMP 100%, hypothermic machine perfusion with 100% 
oxygen. The data are shown as mean±SD.* p<0.05 significance between CS and all HMP 
groups.  
Figure 3. Parameters of metabolism.  
(A ) Oxygen consumption. * p<0,05 significance between CS and all HMP groups, (B) ATP 
content in kidney tissue after thirty minutes warm ischemia (timepoint 0,5), 24 hours 
preservation (timepoint 24) and at the end of 240 minutes normothermic machine perfusion 
(Timepoint 28). * p<0.05 significance between HMP 100%  and all other groups, ** p<0,05 
significance between HMP 100% and HMP 21 and 0%, # p<0,05 significance between 
HMP0% and all other groups, (C) Metabolic coupling. * p<0,05 significance between CS and 







oxygen; HMP 21%, hypothermic machine perfusion oxygenated with air; HMP 100%, 
hypothermic machine perfusion with 100% oxygen. The data are shown as mean±SD. 
Figure 4. Parameters of oxidative stress during preservation and testing. Samples were taken 
during hypothermic and normothermic machine perfusion for oxidative stress analysis (A) 
TBARS concentrations at 15, 60, and 24 hours  measured in the UW solution during 
hypothermic machine perfusion, (B)  TBARS concentrations in plasma  at  15, 60, 120, 180 
and  240 minutes after normothermic machine perfusion, *p<0,05 significance between CS 
and all HMP groups, (C)  TBARS concentrations in the urine at  15, 60, 120, 180 and  240 
minutes after normothermic machine perfusion, ^ p<0,05 significant difference between CS 
and HMP21 and 100%, @ p<0,05 significance between HMP0 and HMP21%, $ p<0,05 
significant difference between CS, HMP0% and HMP21%. TBARS, thiobarbituric acid-
reactive substances; CS, cold storage; HMP 0%, hypothermic machine perfusion with no 
oxygen; HMP 21%, hypothermic machine perfusion oxygenated with air; HMP 100%, 
hypothermic machine perfusion with 100% oxygen. The data are shown as mean±SD. 
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